Vimarsana
Biggest News Aggregation in the World

Page 29 - Double Blind Study News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Double Blind Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Double Blind Study Today - Breaking & Trending Today

In Real World, Patients With Myeloma Have Worse Outcomes - Vimarsana News

In Real World, Patients With Myeloma Have Worse Outcomes

A new analysis found that patients with multiple myeloma receiving standard therapies have much worse outcomes compared with those treated in clinical trials.

Vegan Diet May Curb Hot Flashes by Altering the Microbiome - Vimarsana News

Vegan Diet May Curb Hot Flashes by Altering the Microbiome

An exploratory analysis reveals potential associations between a dietary intervention and both a reduction in postmenopausal vasomotor symptoms and changes in the gut microbiome.

Genetic Testing Warranted in Epilepsy of Unknown Origin - Vimarsana News

Genetic Testing Warranted in Epilepsy of Unknown Origin

Benefits of genetic testing in adults with unexplained epilepsy include enrollment in a clinical trial of a relevant gene therapy, connection to families with a similar diagnosis, and peace of mind.

What's Behind the Scramble for Semaglutide? - Vimarsana News

What's Behind the Scramble for Semaglutide?

Demand for a diabetes medicine called Ozempic is soaring as people take it to shed pounds, leading to shortages in countries including Britain, Germany, Belgium and the United States.

FDA Staff Flags Concerns on Merck's Chronic Cough Drug - Vimarsana News

FDA Staff Flags Concerns on Merck's Chronic Cough Drug

The U.S. health regulator's staff on Wednesday flagged concerns that data on Merck's chronic cough drug might not be enough to prove the treatment's meaningful benefit.